Page 56 - யேல் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

March 17, 2021 Over the last year, an abundance of clinical research has been undertaken to understand common pathologies of COVID-19 illness, including the high rates of thrombosis and endothelial injury. A new state-of-the-art review notes that while an optimal antithrombotic therapy has yet to be determined and appears to be debatable, the ongoing studies provide needed clues and hope for improving outcomes. “There is so much heterogeneity in protocols that hospitals are using for their ward patients, for their critically ill patients, and even for outpatients,” said senior author Behnood Bikdeli, MD (Brigham and Women’s Hospital, Boston, MA, and Yale University School of Medicine, New Haven, CT). “Then you have all these studies, with people feeling so strongly about one particular regimen versus the other. We thought: enough is enough. Let s systematically look to see what s out there.”

United statesBehnood bikdeliAzitah talasazInternational clinical trials registry platformPharmd tehran university of medical sciencesJournal of the american college cardiologyYale university school of medicineImpact of pandemic researchYale university schoolNew havenAmerican collegeClinical trials registry platformTehran universityMedical sciencesPandemic researchஒன்றுபட்டது மாநிலங்களில்